Correction: Ortiz-Islas et al. Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128.
Saved in:
| Title: | Correction: Ortiz-Islas et al. Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128. |
|---|---|
| Authors: | Ortiz-Islas E; Laboratorio de Neurofarmacologia Molecular y Nanotecnologia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico., Montes P; Laboratorio de Neuroinmunoendocrinología, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico., Rodríguez-Pérez CE; Laboratorio de Neurofarmacologia Molecular y Nanotecnologia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico., Ruiz-Sánchez E; Laboratorio de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico., Sánchez-Barbosa T; Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.; Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City 07360, Mexico., Pichardo-Rojas D; Programa Prioritario de Epilepsia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico., Zavala-Tecuapetla C; Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico., Carvajal-Aguilera K; Laboratorio de Nutrición Experimental, Instituto Nacional de Pediatría, Mexico City 04530, Mexico., Campos-Peña V; Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico. |
| Source: | Pharmaceutics [Pharmaceutics] 2025 Dec 18; Vol. 17 (12). Date of Electronic Publication: 2025 Dec 18. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41471143 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Correction: Ortiz-Islas et al. Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ortiz-Islas+E%22">Ortiz-Islas E</searchLink>; Laboratorio de Neurofarmacologia Molecular y Nanotecnologia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.<br /><searchLink fieldCode="AU" term="%22Montes+P%22">Montes P</searchLink>; Laboratorio de Neuroinmunoendocrinología, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Pérez+CE%22">Rodríguez-Pérez CE</searchLink>; Laboratorio de Neurofarmacologia Molecular y Nanotecnologia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.<br /><searchLink fieldCode="AU" term="%22Ruiz-Sánchez+E%22">Ruiz-Sánchez E</searchLink>; Laboratorio de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.<br /><searchLink fieldCode="AU" term="%22Sánchez-Barbosa+T%22">Sánchez-Barbosa T</searchLink>; Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.; Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City 07360, Mexico.<br /><searchLink fieldCode="AU" term="%22Pichardo-Rojas+D%22">Pichardo-Rojas D</searchLink>; Programa Prioritario de Epilepsia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.<br /><searchLink fieldCode="AU" term="%22Zavala-Tecuapetla+C%22">Zavala-Tecuapetla C</searchLink>; Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.<br /><searchLink fieldCode="AU" term="%22Carvajal-Aguilera+K%22">Carvajal-Aguilera K</searchLink>; Laboratorio de Nutrición Experimental, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.<br /><searchLink fieldCode="AU" term="%22Campos-Peña+V%22">Campos-Peña V</searchLink>; Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101534003%22">Pharmaceutics</searchLink> [Pharmaceutics] 2025 Dec 18; Vol. 17 (12). <i>Date of Electronic Publication: </i>2025 Dec 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101534003 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1999-4923 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219994923%22">19994923 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceutics <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41471143 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/pharmaceutics17121625 Languages: – Code: eng Text: English Titles: – TitleFull: Correction: Ortiz-Islas et al. Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ortiz-Islas E – PersonEntity: Name: NameFull: Montes P – PersonEntity: Name: NameFull: Rodríguez-Pérez CE – PersonEntity: Name: NameFull: Ruiz-Sánchez E – PersonEntity: Name: NameFull: Sánchez-Barbosa T – PersonEntity: Name: NameFull: Pichardo-Rojas D – PersonEntity: Name: NameFull: Zavala-Tecuapetla C – PersonEntity: Name: NameFull: Carvajal-Aguilera K – PersonEntity: Name: NameFull: Campos-Peña V IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 12 Text: 2025 Dec 18 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 1999-4923 Numbering: – Type: volume Value: 17 – Type: issue Value: 12 Titles: – TitleFull: Pharmaceutics Type: main |
| ResultId | 1 |